English

BioStock: Chordate Medical’s CEO on UK market introduction

Report this content

Chordate Medical recently began marketing introduction of its migraine treatment in the UK with the help of marketing consultants Futures.Health LTD. In addition, the list change to Nasdaq First North Growth Market is now completed. BioStock contacted Anders Weilandt for a comment.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/02/chordate-medicals-ceo-on-uk-market-introduction/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Chordate Medical’s CEO on UK market introduction
Tweet this